• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯霉素和磺胺甲噁唑固体分散体的溶出速率增强、体外评价及药物释放动力学研究。

Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersions.

机构信息

Aston Pharmacy School, Aston University, Birmingham, UK.

出版信息

Drug Dev Ind Pharm. 2013 May;39(5):704-15. doi: 10.3109/03639045.2012.689763. Epub 2012 May 29.

DOI:10.3109/03639045.2012.689763
PMID:22639985
Abstract

Formulation of solid dispersions is one of the effective methods to increase the rate of solubilization and dissolution of poorly soluble drugs. Solid dispersions of chloramphenicol (CP) and sulphamethoxazole (SX) as model drugs were prepared by melt fusion method using polyethylene glycol 8000 (PEG 8000) as an inert carrier. The dissolution rate of CP and SX were rapid from solid dispersions with low drug and high polymer content. Characterization was performed using fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM). FTIR analysis for the solid dispersions of CP and SX showed that there was no interaction between PEG 8000 and the drugs. Hyper-DSC studies revealed that CP and SX were converted into an amorphous form when formulated as solid dispersion in PEG 8000. Mathematical analysis of the release kinetics demonstrated that drug release from the various formulations followed different mechanisms. Permeability studies demonstrated that both CP and SX when formulated as solid dispersions showed enhanced permeability across Caco-2 cells and CP can be classified as well-absorbed compound when formulated as solid dispersions.

摘要

固体分散体的形成是提高难溶性药物溶出度和溶解速度的有效方法之一。以聚乙二醇 8000(PEG 8000)为惰性载体,采用熔融共融法制备了氯霉素(CP)和磺胺甲恶唑(SX)的固体分散体作为模型药物。具有低药物和高聚合物含量的固体分散体具有快速的 CP 和 SX 溶解速率。采用傅里叶变换红外光谱(FTIR)、差示扫描量热法(DSC)和扫描电子显微镜(SEM)进行了表征。CP 和 SX 固体分散体的 FTIR 分析表明,PEG 8000 与药物之间没有相互作用。高 DSC 研究表明,CP 和 SX 在 PEG 8000 中形成固体分散体时转化为无定形形式。释放动力学的数学分析表明,各种制剂中药物的释放遵循不同的机制。渗透研究表明,CP 和 SX 制成固体分散体时均可增强穿过 Caco-2 细胞的渗透性,CP 制成固体分散体时可被归类为吸收良好的化合物。

相似文献

1
Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersions.氯霉素和磺胺甲噁唑固体分散体的溶出速率增强、体外评价及药物释放动力学研究。
Drug Dev Ind Pharm. 2013 May;39(5):704-15. doi: 10.3109/03639045.2012.689763. Epub 2012 May 29.
2
Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.非那西丁和保泰松与聚乙二醇8000的固体分散体的物理化学表征、药物聚合物溶解及体外评价
J Pharm Sci. 2011 Oct;100(10):4281-94. doi: 10.1002/jps.22613. Epub 2011 May 10.
3
Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.泼尼松:聚乙二醇6000速释片固体分散体的研制:固态表征、溶出行为及处方参数
AAPS PharmSciTech. 2007 Dec 14;8(4):E108. doi: 10.1208/pt0804108.
4
Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.罗非昔布-聚乙二醇4000固体分散体及基于固体分散体的片剂的特性
Pharm Dev Technol. 2005;10(4):467-77. doi: 10.1080/10837450500299701.
5
Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.格列齐特-聚乙二醇4000固体分散体的制备与表征
Acta Pharm. 2009 Mar;59(1):57-65. doi: 10.2478/v10007-009-0001-3.
6
Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.新型脂质制剂增强了难溶性模型药物吡罗昔康的体外溶出度和通透性特征。
Int J Pharm. 2005 Sep 14;301(1-2):209-16. doi: 10.1016/j.ijpharm.2005.05.032.
7
Dissolution rate of furosemide from polyethylene glycol solid dispersions.速尿从聚乙二醇固体分散体中的溶出速率。
Farmaco. 1997 Oct;52(10):625-9.
8
Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.以聚乙二醇(PEG)、滑石粉以及PEG-滑石粉作为分散载体的布洛芬固体分散体的制备、表征及溶出度研究
Drug Dev Ind Pharm. 1998 May;24(5):455-62. doi: 10.3109/03639049809085643.
9
Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.使用水溶性载体对难溶性药物的溶出度增强及药物释放的数学建模研究。
Eur J Pharm Biopharm. 2007 Jan;65(1):26-38. doi: 10.1016/j.ejpb.2006.07.007. Epub 2006 Jul 20.
10
Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.通过固体分散体和包合物提高蛇葡萄素的溶解度。
J Pharm Biomed Anal. 2005 Jul 1;38(3):457-64. doi: 10.1016/j.jpba.2005.01.030. Epub 2005 Mar 2.

引用本文的文献

1
Enhancing drug administration in : a method for using solid dispersions for improved solubility and bioavailability.增强药物给药:一种使用固体分散体提高溶解度和生物利用度的方法。
Fly (Austin). 2025 Dec;19(1):2497565. doi: 10.1080/19336934.2025.2497565. Epub 2025 Apr 25.
2
Enhancing hepatoprotective action: oxyberberine amorphous solid dispersion system targeting TLR4.增强肝保护作用:靶向 TLR4 的小檗碱无定形固体分散系统。
Sci Rep. 2024 Jun 28;14(1):14924. doi: 10.1038/s41598-024-65190-2.
3
Formulation and Characterization of Polymeric Cross-Linked Hydrogel Patches for Topical Delivery of Antibiotic for Healing Wound Infections.
用于局部递送抗生素以治疗伤口感染的聚合物交联水凝胶贴片的配方与表征
Polymers (Basel). 2023 Mar 27;15(7):1652. doi: 10.3390/polym15071652.
4
Chitosan Derivatives with Mucoadhesive and Antimicrobial Properties for Simultaneous Nanoencapsulation and Extended Ocular Release Formulations of Dexamethasone and Chloramphenicol Drugs.具有粘膜粘附性和抗菌性能的壳聚糖衍生物用于地塞米松和氯霉素药物的同步纳米包封及延长眼用释放制剂
Pharmaceutics. 2020 Jun 26;12(6):594. doi: 10.3390/pharmaceutics12060594.
5
The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.重组无序的无定形药物制剂科学的必要性。
Pharm Res. 2017 Sep;34(9):1754-1772. doi: 10.1007/s11095-017-2174-7. Epub 2017 May 18.
6
Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization.采用喷雾干燥或冷冻干燥法制备时,药物-固体分散体(Soluplus®)与药物-聚乙二醇6000分散体的体外性能差异研究。
Saudi Pharm J. 2017 Mar;25(3):419-439. doi: 10.1016/j.jsps.2016.09.013. Epub 2016 Sep 30.